Xiaolin Liang, Yanqing Xie, Yi Gao, Yumin Zhou, Wenhua Jian, Mei Jiang, Hongyu Wang, Jinping Zheng
{"title":"样条法估计肺年龄及其在慢性呼吸系统疾病中的应用。","authors":"Xiaolin Liang, Yanqing Xie, Yi Gao, Yumin Zhou, Wenhua Jian, Mei Jiang, Hongyu Wang, Jinping Zheng","doi":"10.1038/s41533-022-00293-9","DOIUrl":null,"url":null,"abstract":"<p><p>Lung age is a simplified concept that makes spirometry data easier to understand, but it is not widely used due to limitations in estimation methods. The aim of this study was to develop new equations to estimate lung age and to explore the application value of lung age in chronic respiratory diseases. Retrospective spirometric data of 18- to 80-year-old healthy subjects were used to develop the lung age estimation equations. Models were respectively built by multiple linear regression, piecewise linear regression, and the natural cubic spline method. Patients with chronic obstructive pulmonary disease (COPD) and asthma were subdivided into stages I-IV according to the severity of airflow limitation under the recommendation of the Global Initiative for Chronic Obstructive Lung Disease. Propensity score matching was performed to balance age, height and sex between healthy subjects and patients. The difference between lung age and chronological age (∆ lung age) of patients with COPD and asthma was analyzed. A total of 3409 healthy subjects, 280 patients with COPD and 285 patients with asthma data were included in the analysis. The lung age estimation equation with the best goodness of fit was built by the spline method and composed of FEV<sub>1</sub>, FEF<sub>50%</sub>, FEF<sub>75%</sub> and height as explanatory variables. ∆ lung age progressively increased with the degree of airflow limitation in patients with COPD or asthma. Lung age estimation equations were developed by a spline modeling method. Lung age may be used in the assessment of chronic respiratory patients.</p>","PeriodicalId":19470,"journal":{"name":"NPJ Primary Care Respiratory Medicine","volume":" ","pages":"36"},"PeriodicalIF":3.1000,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522795/pdf/","citationCount":"1","resultStr":"{\"title\":\"Estimation of lung age via a spline method and its application in chronic respiratory diseases.\",\"authors\":\"Xiaolin Liang, Yanqing Xie, Yi Gao, Yumin Zhou, Wenhua Jian, Mei Jiang, Hongyu Wang, Jinping Zheng\",\"doi\":\"10.1038/s41533-022-00293-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Lung age is a simplified concept that makes spirometry data easier to understand, but it is not widely used due to limitations in estimation methods. The aim of this study was to develop new equations to estimate lung age and to explore the application value of lung age in chronic respiratory diseases. Retrospective spirometric data of 18- to 80-year-old healthy subjects were used to develop the lung age estimation equations. Models were respectively built by multiple linear regression, piecewise linear regression, and the natural cubic spline method. Patients with chronic obstructive pulmonary disease (COPD) and asthma were subdivided into stages I-IV according to the severity of airflow limitation under the recommendation of the Global Initiative for Chronic Obstructive Lung Disease. Propensity score matching was performed to balance age, height and sex between healthy subjects and patients. The difference between lung age and chronological age (∆ lung age) of patients with COPD and asthma was analyzed. A total of 3409 healthy subjects, 280 patients with COPD and 285 patients with asthma data were included in the analysis. The lung age estimation equation with the best goodness of fit was built by the spline method and composed of FEV<sub>1</sub>, FEF<sub>50%</sub>, FEF<sub>75%</sub> and height as explanatory variables. ∆ lung age progressively increased with the degree of airflow limitation in patients with COPD or asthma. Lung age estimation equations were developed by a spline modeling method. Lung age may be used in the assessment of chronic respiratory patients.</p>\",\"PeriodicalId\":19470,\"journal\":{\"name\":\"NPJ Primary Care Respiratory Medicine\",\"volume\":\" \",\"pages\":\"36\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2022-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522795/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Primary Care Respiratory Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41533-022-00293-9\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PRIMARY HEALTH CARE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Primary Care Respiratory Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41533-022-00293-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 1
摘要
肺年龄是一个简化的概念,使肺活量测定数据更容易理解,但由于估计方法的局限性,它没有被广泛使用。本研究旨在建立新的肺年龄估算方程,探讨肺年龄在慢性呼吸系统疾病中的应用价值。采用18- 80岁健康受试者的回顾性肺活量测定数据建立肺年龄估计方程。分别采用多元线性回归、分段线性回归和自然三次样条法建立模型。根据全球慢性阻塞性肺疾病倡议(Global Initiative for chronic obstructive Lung disease)的建议,将慢性阻塞性肺疾病(COPD)和哮喘患者根据气流限制的严重程度细分为I-IV期。在健康受试者和患者之间进行倾向评分匹配以平衡年龄、身高和性别。分析COPD合并哮喘患者肺年龄与实足年龄(∆肺年龄)的差异。共有3409名健康受试者、280名COPD患者和285名哮喘患者的数据被纳入分析。以FEV1、FEF50%、FEF75%和身高为解释变量,采用样条法建立拟合优度最佳的肺龄估计方程。∆肺年龄随着COPD或哮喘患者气流受限程度的增加而逐渐增加。采用样条建模方法建立了肺龄估计方程。肺年龄可用于慢性呼吸系统患者的评估。
Estimation of lung age via a spline method and its application in chronic respiratory diseases.
Lung age is a simplified concept that makes spirometry data easier to understand, but it is not widely used due to limitations in estimation methods. The aim of this study was to develop new equations to estimate lung age and to explore the application value of lung age in chronic respiratory diseases. Retrospective spirometric data of 18- to 80-year-old healthy subjects were used to develop the lung age estimation equations. Models were respectively built by multiple linear regression, piecewise linear regression, and the natural cubic spline method. Patients with chronic obstructive pulmonary disease (COPD) and asthma were subdivided into stages I-IV according to the severity of airflow limitation under the recommendation of the Global Initiative for Chronic Obstructive Lung Disease. Propensity score matching was performed to balance age, height and sex between healthy subjects and patients. The difference between lung age and chronological age (∆ lung age) of patients with COPD and asthma was analyzed. A total of 3409 healthy subjects, 280 patients with COPD and 285 patients with asthma data were included in the analysis. The lung age estimation equation with the best goodness of fit was built by the spline method and composed of FEV1, FEF50%, FEF75% and height as explanatory variables. ∆ lung age progressively increased with the degree of airflow limitation in patients with COPD or asthma. Lung age estimation equations were developed by a spline modeling method. Lung age may be used in the assessment of chronic respiratory patients.
期刊介绍:
npj Primary Care Respiratory Medicine is an open access, online-only, multidisciplinary journal dedicated to publishing high-quality research in all areas of the primary care management of respiratory and respiratory-related allergic diseases. Papers published by the journal represent important advances of significance to specialists within the fields of primary care and respiratory medicine. We are particularly interested in receiving papers in relation to the following aspects of respiratory medicine, respiratory-related allergic diseases and tobacco control:
epidemiology
prevention
clinical care
service delivery and organisation of healthcare (including implementation science)
global health.